About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Cell Protein Could Play a Role in Drug-resistant Tumours

by Gopalan on October 3, 2007 at 11:47 AM
Font : A-A+

Cell Protein Could Play a Role in Drug-resistant Tumours

Drug-resistant diseases are engaging the attention of the medical community the world over.

Now Australian researchers say they have found that a cell protein plays a key role in "prote cting" cancer cells from a wide range of chemotherapeutic drugs.

Advertisement

A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, have identified the âIII-tubulin component of the cell's cytoskeleton as being responsible for resistance to drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths.
Advertisement

Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of âIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the journal Cancer Research, Associate Professor Kavallaris and her team showed that blocking the expression of the âIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

"Our results strongly suggest that the âIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.

"This is the first scientific evidence for the broader implications of abnormal expression of this protein.

"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.

Source: Medindia
GPL/C
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Tumor Markers For Cancer Diagnosis and Prognosis Diet and Nutrition Tips for Athletes 

Recommended Reading
Powerful Lung Cancer Suppressor Identified
Researchers have identified a gene LKB1 that acts as a tumour suppressor, and mutation in which ......
Development of the New Cancer Stem Cells can Facilitate Breast Cancer Research
Robert Weinberg member of the lab of whitehead has created breast cancer stem cells in a petridish ....
Diet and Nutrition Tips for Athletes
Athletes can be physically fit by consuming a well balanced nutritious diet, which keeps them mental...
Tumor Markers For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)